Application of Ultrasound Imaging Reporting and Data System

doi:10.7517/issn.1674-0475.201012

Abstract

Abstract: Ultrasound imaging reporting and data system is a classification system for diagnosis by multiple ultrasonic features of lesions. The purpose is to standardize the expression of imaging diagnosis, and to solve the communication problem between sonographers and clinicians, so as to provide suggestions for the follow-up, biopsy and treatment of the lesion. Different versions of ultrasound imaging reporting and data systems have been applied to clinical practice. This article introduces several kinds of ultrasound imaging reporting and data systems which are widely used in clinic, including breast, thyroid, ovarian and liver ultrasound imaging reporting and data systems.

Key words: imaging report and data system, ultrasonography, breast neoplasms, thyroid neoplasms, liver neoplasms

XIAO Dandan, LIU Yanna. Application of Ultrasound Imaging Reporting and Data System[J]. IMAGING SCIENCE AND PHOTOCHEMISTRY, 2021, 39(3): 428-433.

References

[1] 中国抗癌协会乳腺专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019,29(8):609-680.
[2] Mercado C L.BI-RADS update[J].Radiologic Clinics of North America, 2014,52(3):481-487.
[3] 朱庆莉, 姜玉新. 乳腺影像报告与数据系统指南(第5版)超声内容更新介绍[J].中华医学超声杂志(电子版), 2016,13(1):5-7.
[4] 王立平, 蒋天安, 杨琛, 等. 乳腺良性结节超声BI-RADS分级的可靠性及其影响因素分析[J].中华超声影像学杂志,2011,20(4):314-317.
[5] 朱巧英, 周锋盛, 周婉, 等. 灰阶超声造影对乳腺BI-RADS-US 4类病灶的应用价值[J].中华超声影像学杂志, 2015,24(10):890-893.
[6] Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management[J].Journal of Clinical Endocrinology and Metabolism, 2009,94(5):1748-1751.
[7] Tessler F N, Middleton W D, Grant E G, et al. ACR thyroid imaging, reporting and data system(TI-RADS):white paper of the ACR TI-RADS committee[J].Journal of the American College of Cardiology, 2017,14(5):587-595.
[8] 刘红, 胡正明, 罗海愉, 等.ACR TI-RADS分类在诊断甲状腺结节中的应用价值探究[J]. 中国超声医学杂志.2018,34(8):673-675.
[9] 傅强, 熊颖, 闫妍, 等.三种甲状腺影像报告和数据系统临床应用评估[J].中国医学装备, 2020,17(6):33-37.
[10] Middleton W D, Teefey S A, Reading C C, et al. Comparison of performance characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association guidelines[J]. American Journal of Roentgenology, 2018,210(5):1148-1154.
[11] 杨艳. 超声TI-RADS分类对甲状腺结节的诊断价值[J].影像研究与医学应用, 2018,2(16):117-118.
[12] 王盼盼.彩超诊断甲状腺结节的特征分析[J].医学食疗与健康, 2020,18(18):171-172.
[13] 梁晓雯, 陈智毅.甲状腺结节超声分类诊断研究进展[J].中华超声影像学杂志, 2018,27(9):823-826, 828.
[14] 刘锐洪, 何瑞琦, 陈英银, 等. ACR TI-RADS与ATA指南分级评估甲状腺结节的对比研究[J].中国中西医结合影像学杂志, 2019,7(4):380-383.
[15] 赵静, 赵利辉, 忻晓洁, 等. 甲状腺滤泡癌与甲状腺乳头状癌的TI-RADS分类及超声特征分析[J].中华普通外科杂志, 2016,31(9):754-757.
[16] Zhu L C, Ye L Y, Luo W H, et al. A model to discriminate malignant from benign thyroid nodules using artificial neural network[J].PLoS One, 2013,8:e82211.
[17] Wildman-Tobriner B, Buda M, Hoang J K, et al. Using artificial intelligence to revise ACR TI-RADS risk stratification of thyroid nodules:diagnostic accuracy and utility[J].Radiology, 2019,292(1):112-119.
[18] Amor F, Vaccaro H, Alcázar J L, et al. Gynecologic imaging reporting and data system:A new proposal for classifying adnexal masses on the basis of sonographic findings[J].Journal of Ultrasound in Medicine, 2009,28(3):285-291.
[19] Andreotti R, Timmerman D, Strachowski L, et al. O-RADS US risk stratification and management system:a consensus guideline from the ACR Ovarian-adnexal Reporting and Data System Committee[J].Radiology, 2020,294(1):168-185.
[20] Basha M A A, Metwally M I, Gamil S A, et al. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses[J].European Radiology, 2021,31(2):674-684.
[21] 杨丹, 李锐. 美国放射学院超声造影LI-RADS指南(2016版)[J]. 临床超声医学杂志, 2017,19(10):712-718.
[22] Chernyak V, Fowler K, Kamaya A, et al. Liver imaging reporting and data system (LI-RADS) Version 2018:imaging of hepatocellular carcinoma in at-risk patients[J].Radiology, 2018,289(3):816-830.
[23] Fetzer D T, Rodgers S K, Harris A C, et al. Screening and surveillance of hepatocellular carcinoma:an introduction to ultrasound liver imaging reporting and data system[J].Radiologic Clinics of North America, 2017,55(6):1197-1209.
[24] Bruix J, Ayuso C. Diagnosis of hepatic nodules in patients at risk for hepatocellular carcinoma:LI-RADS probability versus certainty[J]. Gastroenterology, 2019,156(4):860-862.
[25] Henderson M, Silver M, Tran Q, et al. A noninvasive blood-based combinatorial proteomic biomarker assay to detect breast cancer in women over age 50 with BI-RADS 3, 4, or 5 assessment[J]. Clinical Cancer Research, 2019,25(1):142-149.
[26] 马姣姣, 张波. 甲状腺结节超声风险分层的利与弊[J]. 中国癌症杂志, 2020,30(7):546-550.
[27] Yau T, Tang V, Yao T, et al. Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma[J].Gastroenterology, 2014,146(7):1691-1700.